BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31980417)

  • 21. Ultra-low coverage whole genome sequencing of ccfDNA in multiple myeloma: A tool for laboratory routine?
    Rengifo LY; Smits S; Buedts L; Delforge M; Dehaspe L; Tousseyn T; Boeckx N; Lehnert S; Michaux L; Vermeesch JR; Vandenberghe P; Dewaele B
    Cancer Treat Res Commun; 2021; 28():100380. PubMed ID: 33962213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients.
    Hamdaoui H; Benlarroubia O; Ait Boujmia OK; Mossafa H; Ouldim K; Belkhayat A; Smyej I; Benrahma H; Dehbi H; Chegdani F
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1363. PubMed ID: 32573970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal defects in multiple myeloma.
    Clarke SE; Fuller KA; Erber WN
    Blood Rev; 2024 Mar; 64():101168. PubMed ID: 38212176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of IGH Profile Signals Using t(4;14) and IGH Break-Apart Probes by FISH in Multiple Myeloma.
    Smol T; Daudignon A
    Cytogenet Genome Res; 2017; 153(1):18-21. PubMed ID: 29040969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic tools for risk-stratification in multiple myeloma].
    Braggio E; Albarracín Garramuño F
    Medicina (B Aires); 2013; 73(4):369-75. PubMed ID: 23924539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16).
    Duek A; Trakhtenbrot L; Amariglio N; Benyamini N; Zilbershats I; Ganzel C; Shevetz O; Leiba R; Rozic G; Nagler A; Leiba M
    Genes Chromosomes Cancer; 2019 Aug; 58(8):516-520. PubMed ID: 30675954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on molecular cytogenetic abnormalities in multiple myeloma].
    Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
    Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma.
    Peña-Pérez L; Frengen N; Hauenstein J; Gran C; Gustafsson C; Eisfeldt J; Kierczak M; Taborsak-Lines F; Olsen RA; Wallblom A; Krstic A; Ewels P; Lindstrand A; Månsson R
    Blood Adv; 2022 Sep; 6(17):5009-5023. PubMed ID: 35675515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma.
    Tsukamoto T; Kinoshita M; Yamada K; Ito H; Yamaguchi T; Chinen Y; Mizutani S; Fujino T; Kobayashi T; Shimura Y; Inazawa J; Kuroda J
    J Hum Genet; 2023 Jul; 68(7):507-514. PubMed ID: 36882509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.
    Våtsveen TK; Tian E; Kresse SH; Meza-Zepeda LA; Gabrea A; Glebov O; Dai HY; Sundan A; Kuehl WM; Børset M
    Leuk Res; 2009 Dec; 33(12):1670-7. PubMed ID: 19395026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
    Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
    Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of 14q32 rearrangements in multiple myeloma, using simultaneous FISH analysis combined with immunofluorescence.
    Abaza HM; Youssef SR; Saad AA; Kamal GM; Hegazy MG; Ibrahim RI; Annaka LM
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):56-63. PubMed ID: 25929730
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Hui H; Fuller KA; Eresta Jaya L; Konishi Y; Ng TF; Frodsham R; Speight G; Yamada K; Clarke SE; Erber WN
    J Clin Pathol; 2023 Nov; 76(11):763-769. PubMed ID: 36113967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.